Page last updated: 2024-08-21

treosulfan and Genetic Diseases, X-Chromosome Linked

treosulfan has been researched along with Genetic Diseases, X-Chromosome Linked in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (50.00)	24.3611
2020's	1 (50.00)	2.80

Authors

Authors	Studies
Jayakumar, I; Melarcode Ramanan, K; Patel, S; Raj, R; Ravichandran, N; Uppuluri, R; Vaidhyanathan, L; Vellaichamy Swaminathan, V	1
Hiwarkar, P; Lawson, S; Motwani, J; O'Rafferty, C; Velangi, M	1

Other Studies

2 other study(ies) available for treosulfan and Genetic Diseases, X-Chromosome Linked

Article	Year
Treosulfan-based reduced toxicity hematopoietic stem cell transplantation in X-linked agammaglobulinemia: A cost-effective alternative to long-term immunoglobulin replacement in developing countries. Pediatric transplantation, 2020, Volume: 24, Issue:1 Topics: Agammaglobulinemia; Busulfan; Cost-Benefit Analysis; Developing Countries; Drug Therapy, Combination; Genetic Diseases, X-Linked; Hematopoietic Stem Cell Transplantation; Humans; Immunoglobulins, Intravenous; Immunosuppressive Agents; India; Infant; Male; Transplantation Conditioning	2020
IFNɣ Block, Treosulfan Conditioning and αβ T Cell Deplete PBSCT for XIAP-Deficient HLH. Journal of clinical immunology, 2017, Volume: 37, Issue:6 Topics: Antibodies, Blocking; Antibodies, Monoclonal; Antigens, CD19; Busulfan; Chimerism; Genetic Diseases, X-Linked; Humans; Infant; Infant, Newborn; Interferon-gamma; Lymphocyte Depletion; Lymphoproliferative Disorders; Male; Peripheral Blood Stem Cell Transplantation; Receptors, Antigen, T-Cell, alpha-beta; T-Lymphocytes; Transplantation Conditioning; X-Linked Inhibitor of Apoptosis Protein	2017

Article

Year

Treosulfan-based reduced toxicity hematopoietic stem cell transplantation in X-linked agammaglobulinemia: A cost-effective alternative to long-term immunoglobulin replacement in developing countries.

Pediatric transplantation, 2020, Volume: 24, Issue:1

Topics: Agammaglobulinemia; Busulfan; Cost-Benefit Analysis; Developing Countries; Drug Therapy, Combination; Genetic Diseases, X-Linked; Hematopoietic Stem Cell Transplantation; Humans; Immunoglobulins, Intravenous; Immunosuppressive Agents; India; Infant; Male; Transplantation Conditioning

2020

IFNɣ Block, Treosulfan Conditioning and αβ T Cell Deplete PBSCT for XIAP-Deficient HLH.

Journal of clinical immunology, 2017, Volume: 37, Issue:6

Topics: Antibodies, Blocking; Antibodies, Monoclonal; Antigens, CD19; Busulfan; Chimerism; Genetic Diseases, X-Linked; Humans; Infant; Infant, Newborn; Interferon-gamma; Lymphocyte Depletion; Lymphoproliferative Disorders; Male; Peripheral Blood Stem Cell Transplantation; Receptors, Antigen, T-Cell, alpha-beta; T-Lymphocytes; Transplantation Conditioning; X-Linked Inhibitor of Apoptosis Protein

2017